Baillie Gifford acquired 16.2M Royalty Pharma plc shares worth $889M. That's 0.72% of their equity portfolio (28th largest holding). The investor owns 3.71% of the outstanding Royalty Pharma plc stock. The first Royalty Pharma plc trade was made in Q1 2022. Since then Baillie Gifford bought shares three more times and sold shares on thirteen occasions. The stake costed the investor $633M, netting the investor a gain of 41% so far.